like what you said, ace.
well done holding mate.
let me give you a leg up with sharing the research.
Layman's guidance on ATL1102:
backstory
*stem cell transplant improves clinical outcomes on chemo patients
*blood cells produced in the bone marrow arise from stem cells
*known as hematopoietic, the stem cells are collected from a patient's blood pre-chemo
*because there are only a small number of stem cells in the blood, a growth agent is needed
*growth agents are known as 'mobilization' agents
*mobilization agents are identified by a protein marker (eg. CD34+)
*granulocyte colony-stimulating factor (G-CSF) is the main agent for mobilization of stem cells
*the market for G-CSF is upwards of US$3b pa
*G-CSF, as a successful pathway to mobilization, is enhanced by Mobozil
*first marketed in 2009, Mobozil's 2010 sales ~ US$100m pa
*sales of Mobozil are forecast to rise to ~ US$350m pa
*yet a clinical need still exists to improve on stem cell release achieved by G-CSF/Mobozil
enter ATL1102
*ATL1102 has been found to block a receptor on cells known as VLA-4
*blocking the VLA-4 aids in stem cell release
*ATL1102 is therefore a mobilization agent
pharmacological action and toxicity of ATL1102
*quick pharmacological action (within a week)
*safe and well tolerated toxicity demonstrated in phase II clinical trials of MS patients
*ATL1102 is therefore considered to be at an advanced stage
does ATL1102 demonstrate clinical superiority to G-CSF
*a version of ATL1102 was used in conjunction with G-CSF on mice
*stem cells released increase by a factor of 13 times the mobilization when using G-CSF alone
*ATL1102 therefore shows great potential for improving mobilization of G-CSF
conclusion
ATL1102 has potential to increase mobilization of stem cells harvested for pre-chemo patients
ATL1102 shows clinical superiority to G-CSF by a factor of 13 times
ATL1102 patent is now pending on the mobilization of stem cells
- Forums
- ASX - By Stock
- PER
- witnessing the start of a 5 to Disallowed.
witnessing the start of a 5 to Disallowed., page-238
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.6¢ |
Change
0.005(6.17%) |
Mkt cap ! $77.53M |
Open | High | Low | Value | Volume |
8.2¢ | 8.7¢ | 8.2¢ | $93.35K | 1.100M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 228136 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 18794 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 228136 | 0.084 |
2 | 86585 | 0.082 |
2 | 37321 | 0.081 |
5 | 335350 | 0.080 |
4 | 61541 | 0.079 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 18794 | 1 |
0.087 | 119524 | 2 |
0.088 | 457142 | 2 |
0.089 | 295000 | 3 |
0.090 | 265111 | 5 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |